News | June 23, 2026
FDA advisory panel backs Moderna flu vaccine candidate for older adults
The backing comes as influenza remains a persistent public health burden
The backing comes as influenza remains a persistent public health burden
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
